Used capture and detection antibodies can recognize exosome-specific markers (Rab5, CD63 and CD9), melanocyte-specific proteins (MelanA, MCAM, Tyrosinase) and tumor markers (CEACAM, CD44). The gene discussed is CD63; the disease is neoplasm.